about
Chitin and chitosan as direct compression excipients in pharmaceutical applicationsNovel formulations for antimicrobial peptidesChitosan modification of adenovirus to modify transfection efficiency in bovine corneal epithelial cellsNano chitosan peptide as a potential therapeutic carrier for retinal delivery to treat age-related macular degenerationStudy on biocompatibility of complexes of collagen-chitosan-sodium hyaluronate and cornea.Bioadhesive hyaluronan-chitosan nanoparticles can transport genes across the ocular mucosa and transfect ocular tissue.In vitro damage of Candida albicans biofilms by chitosanNatural extracts into chitosan nanocarriers for rosmarinic acid drug delivery.Natural Bioadhesive Biodegradable Nanoparticle-Based Topical Ophthalmic Formulations for Management of Glaucoma.Improved intraocular bioavailability of ganciclovir by mucoadhesive polymer based ocular microspheres: development and simulation process in Wistar ratsThe potential of chitosan for the oral administration of peptides.Diversity of microbial species implicated in keratitis: a reviewThe performance of nanocarriers for transmucosal drug delivery.Dense chitosan surgical membranes produced by a coincident compression-dehydration process.The use of Chitosan to enhance photodynamic inactivation against Candida albicans and its drug-resistant clinical isolates.Ocular drug delivery: nanomedicine applications.Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases.Chitosan-Based Multifunctional Platforms for Local Delivery of Therapeutics.Ocular drug delivery - a look towards nanobioadhesives.Polymeric vectors for ocular gene delivery.Nanocarriers for ocular delivery for possible benefits in the treatment of anterior uveitis: focus on current paradigms and future directions.Control of the blood-brain barrier function in cancer cell metastasis.Ocular delivery systems for topical application of anti-infective agents.Ultra-small algal chitosan ocular nanoparticles with iron-binding milk protein prevents the toxic effects of carbendazim pesticide.Current treatment strategies and nanocarrier based approaches for the treatment and management of diabetic retinopathy.Nanoparticles for drug delivery to the anterior segment of the eye.Self-aggregated nanoparticles based on amphiphilic poly(lactic acid)-grafted-chitosan copolymer for ocular delivery of amphotericin B.High pH tolerance of a chitosan-PAA nanosuspension for ophthalmic delivery of pilocarpine.Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation.Chitosan nanoparticles for ocular delivery of cyclosporine A.Different particulate systems--bypass the biological barriers?Recent advances in topical nano drug-delivery systems for the anterior ocular segment.Pilocarpine-loaded chitosan-PAA nanosuspension for ophthalmic delivery.Hydroxypropylmethylcellulose films for the ophthalmic delivery of diclofenac sodium.Nanodispersion-loaded mucoadhesive polymeric inserts for prolonged treatment of post-operative ocular inflammation.Preparation and evaluation of chitosan–itraconazole co-precipitated nanosuspension for ocular deliveryWhen nanotechnology meets the ocular surfacePhysicochemical Properties andIn VitroCytotoxicity Studies of Chitosan as a Potential Carrier for Dicer-Substrate siRNA
P2860
Q26825189-C1229568-2FC0-433A-ADB0-68BE0C985A58Q26991771-E128AAC5-56D2-470D-A7B1-6E669C3148E1Q28475072-A7F7F7EC-4D1C-4565-809F-56728B4BF8CCQ30565636-98BDC3D5-DD10-4EC6-9885-FA35BEFB9B32Q33211176-74E22ED6-6BE0-44F3-A057-7380C19ED7F7Q33321483-02AA1417-E990-4F58-979F-E1A2052B73EEQ33962613-11AC8CE6-A252-481F-A0A8-6D8689798635Q35502502-03EB9282-C25D-4561-BB29-70A33866027CQ35691647-9A3A0993-B0B1-4F0F-85C0-24738116B0C2Q36204686-5F6AE983-C8F6-4BC3-A498-75CB43186928Q36316822-3F175687-DDCC-495C-A50C-CB2E4DFFCEC6Q36460600-658B6CA7-36B1-4AD0-826E-2D6B28674FFEQ36527739-70A991EA-1866-4C81-B14F-DB4B8EA2497CQ36756873-7EFDE252-17B3-4957-9073-7426836E211DQ36820457-247F3CBC-1F4F-4142-96F6-D8DF849C08FDQ36918036-4BFC3298-B1D5-4C37-B683-7B88200CAF31Q37638947-304E4C9C-1EBA-4BE6-9966-8F55A97FC240Q37721800-04E98577-A822-445E-8C3B-01456EEDE5AAQ37822756-54F4427E-AD1A-472F-B791-4D8E0682F1A3Q37920729-112070E5-6419-403A-A443-5A309634089DQ38227621-5429DFA2-D73D-490D-A9B1-2600EE4A0D0FQ38511670-0DFE544C-F1F7-45F9-B6EA-A5F83F428F07Q38577846-BB033AEA-2921-49AC-9BCF-683586533401Q38809370-47E87B71-5A9A-4ADB-BC8A-8ED373C634E9Q39103248-80C32C5B-062C-4FD2-B9BB-83B4BA6872E1Q39230212-E34E183B-7D78-457D-AF14-8D507BAD40E1Q41769810-4C528B77-A461-424C-A81E-499D4DF3EECAQ43186984-D8DCC210-E692-49FA-A33F-20DEDB16864EQ43234583-0DED2A82-53D7-4B09-9491-0FE61E4CB8AFQ44640830-4F187F2E-3B18-4363-B678-3E49E3FCC189Q48419057-6F905BA0-0E89-464D-A6F8-47DF8B287C06Q50082031-A9B44B6C-6CCB-4EB3-B62F-9A9935BD0F85Q51060785-04D9570D-3A39-42DA-8765-45442BD428D8Q51282117-AE287C42-2038-4441-944D-C61004F7674FQ52879749-A5F16761-2B61-4BF0-8CB5-1E4260E5F34BQ56027212-9A38FA7F-2D3A-40FC-8FFF-5DCDF7CB4893Q57381955-25815900-86F6-4253-AE69-CED30B3A282AQ59017333-981EE888-9B09-49A0-B722-6E8C7138656A
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
The potential of chitosan in ocular drug delivery.
@ast
The potential of chitosan in ocular drug delivery.
@en
type
label
The potential of chitosan in ocular drug delivery.
@ast
The potential of chitosan in ocular drug delivery.
@en
prefLabel
The potential of chitosan in ocular drug delivery.
@ast
The potential of chitosan in ocular drug delivery.
@en
P2860
P356
P1476
The potential of chitosan in ocular drug delivery
@en
P2093
Alejandro Sánchez
P2860
P304
P356
10.1211/0022357022476
P577
2003-11-01T00:00:00Z